㈜이에이치엘바이오

{
  "address": "경기도 의왕시",
  "ceo_name": "이홍기",
  "certificate": [
    {
      "cert_number": "20150101301",
      "changes": "",
      "disclosure_date": "2015-02-27",
      "first_cert_date": "2015-02-27",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-02-27 ~ 2017-02-26"
    },
    {
      "cert_number": "20170102182",
      "changes": "",
      "disclosure_date": "2017-03-16",
      "first_cert_date": "2015-02-27",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-02-27 ~ 2019-02-26"
    },
    {
      "cert_number": "20190101696",
      "changes": "",
      "disclosure_date": "2019-03-06",
      "first_cert_date": "2015-02-27",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2019-02-27 ~ 2021-02-26"
    },
    {
      "cert_number": "20210102237",
      "changes": "",
      "disclosure_date": "2021-03-17",
      "first_cert_date": "2015-02-27",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2021-02-27 ~ 2023-02-26"
    },
    {
      "cert_number": "20230315020007",
      "changes": "",
      "disclosure_date": "2023-03-15",
      "first_cert_date": "2015-02-27",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2023-02-27 ~ 2026-02-26"
    }
  ],
  "company_name": "㈜이에이치엘바이오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 3018299000,
      "cost_of_sales": 3752562000,
      "current_assets": 7412251000,
      "current_liabilities": 9038990000,
      "gross_profit": 12174150000,
      "net_income": 3962544000,
      "net_income_bs": 3855092000,
      "non_current_assets": 8488734000,
      "non_current_liabilities": 4325938000,
      "non_operating_expenses": 290169000,
      "non_operating_income": 217776000,
      "operating_profit": 4034937000,
      "revenue": 15926712000,
      "sga_expenses": 8139213000,
      "total_assets": 15900985000,
      "total_equity": 2536057000,
      "total_liabilities": 13364928000
    },
    "2023": {
      "capital_stock": 6469990000,
      "cost_of_sales": 4886488000,
      "current_assets": 15698088000,
      "current_liabilities": 17973959000,
      "gross_profit": 13371977000,
      "net_income": -456971000,
      "net_income_bs": -508801000,
      "non_current_assets": 13639837000,
      "non_current_liabilities": 4367051000,
      "non_operating_expenses": 3385610000,
      "non_operating_income": 557032000,
      "operating_profit": 2371607000,
      "revenue": 18258465000,
      "sga_expenses": 11000370000,
      "total_assets": 29337925000,
      "total_equity": 6996915000,
      "total_liabilities": 22341010000
    },
    "2024": {
      "capital_stock": 6919721000,
      "cost_of_sales": 5842657000,
      "current_assets": 14068988000,
      "current_liabilities": 18713035000,
      "gross_profit": 13828699000,
      "net_income": 3129844000,
      "net_income_bs": 3243780000,
      "non_current_assets": 21150903000,
      "non_current_liabilities": 5516112000,
      "non_operating_expenses": 1008520000,
      "non_operating_income": 2504392000,
      "operating_profit": 1633972000,
      "revenue": 19671356000,
      "sga_expenses": 12194727000,
      "total_assets": 35219891000,
      "total_equity": 10990744000,
      "total_liabilities": 24229147000
    }
  },
  "industry": "합성의약품 및 기타 완제 의약품 제조업",
  "investment": [],
  "main_products": "세포치료제줄기세포보관및연구 화장품원료 화장품",
  "phone": "02-535-****",
  "years": [
    2024,
    2023,
    2022
  ]
}